{"id":8152,"date":"2022-12-09T17:13:11","date_gmt":"2022-12-09T09:13:11","guid":{"rendered":"https:\/\/clinicalvalue.com\/liver-disease-in-asia-pacific-insights-from-prof-pierce-chow\/"},"modified":"2024-03-27T13:36:19","modified_gmt":"2024-03-27T05:36:19","slug":"liver-disease-in-asia-pacific-insights-from-prof-pierce-chow","status":"publish","type":"post","link":"https:\/\/clinicalvalue.com\/en-au\/liver-disease-in-asia-pacific-insights-from-prof-pierce-chow\/","title":{"rendered":"Liver Disease in Asia Pacific: Insights from Prof Pierce Chow"},"content":{"rendered":"<p class=\"text-align-justify\">In this Q&amp;A, Prof Pierce Chow of the National Cancer Centre Singapore discusses the epidemiology of liver disease in Asia Pacific; key considerations around the clinical management of common liver diseases like HBV, HCV, fatty liver and HCC; and the critical role of diagnostics in ensuring early detection and effective treatment.<\/p>\n<ul>\n<li class=\"text-align-justify\">[00:09] \u2013 Prof Chow\u2019s current roles<\/li>\n<li class=\"text-align-justify\">[00:57] \u2013 Main risk factors for liver cancer in Asia Pacific<\/li>\n<li class=\"text-align-justify\">[03:25] \u2013 Reasons why HBV is so common in Asia Pacific<\/li>\n<li class=\"text-align-justify\">[04:42] \u2013 Liver cancer burden in Asia Pacific<\/li>\n<li class=\"text-align-justify\">[06:46] \u2013 Best approaches to HCC surveillance<\/li>\n<li class=\"text-align-justify\">[08:10] \u2013 Barriers to accessing HCC surveillance services<\/li>\n<li class=\"text-align-justify\">[10:36] \u2013 Digital tools that improve HCC surveillance services<\/li>\n<li class=\"text-align-justify\">[11:32] \u2013 Key treatments available for liver cancer patients<\/li>\n<li class=\"text-align-justify\">[14:44] \u2013 Lab-clinician collaboration opportunities in liver cancer care<\/li>\n<li class=\"text-align-justify\">[15:46] \u2013 Role of policy makers in liver cancer screening and care<\/li>\n<\/ul>\n<p>Watch the full Q&amp;A below (click the buttons on the play bar to jump to any specific segment that interests you).<\/p>\n<p><iframe loading=\"lazy\" title=\"Liver disease in Asia Pacific: insights from Prof Pierce Chow\" src=\"https:\/\/player.vimeo.com\/video\/554095560?dnt=1&amp;app_id=122963\" width=\"1280\" height=\"720\" frameborder=\"0\" allow=\"autoplay; fullscreen; picture-in-picture; clipboard-write\"><\/iframe><\/p>\n","protected":false},"excerpt":{"rendered":"<p>In this Q&#038;A, Prof Pierce Chow of the National Cancer Centre Singapore discusses the epidemiology of liver disease in Asia Pacific; key considerations around the clinical management of common liver diseases like HBV, HCV, fatty liver and HCC; and the critical role of diagnostics in ensuring early detection and effective treatment&#8230;.<\/p>\n","protected":false},"author":18,"featured_media":7695,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1285],"tags":[1353,1321,1301,1323,1325,1332],"cancer-type":[1296],"country":[1268],"class_list":["post-8152","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-expert-opinions-en-au","tag-fatty-liver-disease-en-au","tag-hbv-en-au","tag-hcc-en-au","tag-hcv-en-au","tag-hepatitis-en-au","tag-liver-en-au","cancer-type-liver-en-au","country-au"],"jetpack_featured_media_url":"https:\/\/clinicalvalue.com\/app\/uploads\/2022\/12\/Liver-Disease-in-Asia-Pacific_-Insights-from-Prof-Pierce-Chow.jpg","_links":{"self":[{"href":"https:\/\/clinicalvalue.com\/en-au\/wp-json\/wp\/v2\/posts\/8152"}],"collection":[{"href":"https:\/\/clinicalvalue.com\/en-au\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clinicalvalue.com\/en-au\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clinicalvalue.com\/en-au\/wp-json\/wp\/v2\/users\/18"}],"replies":[{"embeddable":true,"href":"https:\/\/clinicalvalue.com\/en-au\/wp-json\/wp\/v2\/comments?post=8152"}],"version-history":[{"count":3,"href":"https:\/\/clinicalvalue.com\/en-au\/wp-json\/wp\/v2\/posts\/8152\/revisions"}],"predecessor-version":[{"id":8154,"href":"https:\/\/clinicalvalue.com\/en-au\/wp-json\/wp\/v2\/posts\/8152\/revisions\/8154"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/clinicalvalue.com\/en-au\/wp-json\/wp\/v2\/media\/7695"}],"wp:attachment":[{"href":"https:\/\/clinicalvalue.com\/en-au\/wp-json\/wp\/v2\/media?parent=8152"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clinicalvalue.com\/en-au\/wp-json\/wp\/v2\/categories?post=8152"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clinicalvalue.com\/en-au\/wp-json\/wp\/v2\/tags?post=8152"},{"taxonomy":"cancer-type","embeddable":true,"href":"https:\/\/clinicalvalue.com\/en-au\/wp-json\/wp\/v2\/cancer-type?post=8152"},{"taxonomy":"country","embeddable":true,"href":"https:\/\/clinicalvalue.com\/en-au\/wp-json\/wp\/v2\/country?post=8152"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}